Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(19):1406; doi:10.1093/jnci/dji357
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zielinski, S. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zielinski, S. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

In Brief

Sarah L. Zielinski

The first 10% of the full text of this article appears below.

Routine Testing for BRCA Mutations Not Recommended for General Public

Primary care physicians should not refer all women for genetic testing for BRCA1 and BRCA2 mutations and instead refer only those women whose family history puts them at particularly high risk for these mutations, according to new guidelines from the U.S. Preventive Services Task Force . . . [Full Text of this Article]

Warning Issued on Trastuzumab's Potential Cardiovascular Risks

Final Ethics Rules Announced by NIH


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?